Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022

SELL
$34.2 - $47.56 $13,680 - $19,024
-400 Closed
0 $0
Q2 2021

Aug 13, 2021

SELL
$25.79 - $42.11 $338,777 - $553,156
-13,136 Reduced 97.04%
400 $14,000
Q2 2021

Aug 13, 2021

BUY
$25.79 - $42.11 $338,777 - $553,156
13,136 Added 3284.0%
13,536 $400,000
Q4 2020

Feb 09, 2021

BUY
$34.61 - $123.66 $13,844 - $49,464
400 New
400 $32,000

Others Institutions Holding ARCT

About Arcturus Therapeutics Holdings Inc.


  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $446M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track Liberty Wealth Management LLC Portfolio

Follow Liberty Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Liberty Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Liberty Wealth Management LLC with notifications on news.